Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02217319Completed
Randomised, open-label trial of sevoflurane in Myocardial injury (2 arms), sponsored by Helios Dr. Horst Schmidt Kliniken Wiesbaden. Primary endpoint: High Sensitive Troponin T Release. Started Sep 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02217319.